Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd banner

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
F:GU5

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
F:GU5
Watchlist
Price: 1.51 EUR Market Closed
Market Cap: €4.6B

Intrinsic Value

The intrinsic value for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (GU5) under the Base Case is 1.33 EUR. Compared with the current market price of 1.51 EUR, the stock appears Overvalued by 12% .

Intrinsic value calculated using DCF
€1.33

Do our valuations actually work? See backtest results .

GU5 Intrinsic Value
1.33
Overvaluation 12%
Intrinsic Value
Price €1.51
Monitor GU5
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €1.06
Get notified when the price drops into your buy zone
Current Price €1.51
Intrinsic Value €1.33
Margin of Safety 20% €1.06
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about GU5?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GU5 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd.

Explain Valuation
Alternatives to GU5

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one GU5 stock?

The intrinsic value for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (GU5) under the Base Case is 1.33 EUR.

Is GU5 stock undervalued or overvalued?

Compared with the current market price of 1.51 EUR, the stock appears Overvalued by 12% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett